News
BSX
52.68
-1.62%
-0.87
Thursday's ETF with Unusual Volume: RSPH
NASDAQ · 1d ago
Boston Scientific’s Chronic Pain Study Update: What Investors Should Watch
TipRanks · 1d ago
Is Boston Scientific’s (BSX) ESOP Shelf Plan Quietly Reframing Its Long‑Term Capital Allocation Strategy?
Simply Wall St · 2d ago
Jim Cramer Won't 'Dump' This Medical Device Maker, Passes On Ford
Benzinga · 3d ago
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Seeking Alpha · 4d ago
Weekly Report: what happened at BSX last week (0504-0508)?
Weekly Report · 4d ago
Boston Scientific (BSX) Valuation Check After New Atrial Fibrillation And Stroke Prevention Data
Simply Wall St · 5d ago
Boston Scientific Governance Shift Raises Questions On Investor Influence
Simply Wall St · 05/08 10:31
Boston Scientific to Update Pacemakers in Recall, FDA Says
Dow Jones · 05/07 23:05
Boston Scientific issues correction for ACCOLADE pacemakers, FDA says
TipRanks · 05/07 21:56
Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity
Seeking Alpha · 05/07 16:27
BSX June 26th Options Begin Trading
NASDAQ · 05/07 14:35
*Penumbra Not Be Providing Fincl Guidance Due to Pending Acquisition by Boston Scientific >PEN
Dow Jones · 05/06 20:15
Boston Scientific Shareholders Approve Directors and Governance Changes
TipRanks · 05/05 22:50
Why Is SPDR S&P 500 ETF Trust (SPY) Up Today, 5/5/2026?
TipRanks · 05/05 20:03
Polen Focus Growth Portfolio Q1 2026 Portfolio Update
Seeking Alpha · 05/04 15:32
BSX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
Barchart · 05/04 12:22
Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results
PR Newswire · 05/04 12:00
Boston Scientific (BSX) Receives a Buy from Piper Sandler
TipRanks · 05/04 11:39
Analysts See 16% Upside For The Holdings of MGK
NASDAQ · 05/04 11:19
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.